Microbiology Spectrum · 2021 · 17 citations · 42 references
MedicineInfectious DiseasesImmunizationMedical MicrobiologyPediatric Infectious DiseasesBacterial InfectionsInfectious Disease PreventionVaccinationVaccine-preventable DiseasesAge-specific Vaccine EffectivenessClonal DifferentiationPneumococcal DiseaseSerotype Distribution
We found that with the incorporation of the PCV13 vaccine, the numbers of IPD cases caused by serotypes included in this vaccine decreased in all of the age groups. Still, there was an unforeseen increase of the serotypes not included in this vaccine causing IPD, especially in the >65-year-old group. Moreover, a significant increase of serotype 3 included in the vaccine has been observed; this event has been reported by other researchers. These facts call for the incorporation of more serotypes in future vaccines and a more thorough surveillance of the dynamics of this microorganism.
42
Matthew R. Moore, Ruth Link‐Gelles, William Schaffner et al. · The Lancet Infectious Diseases · 2015 · 730 citations · Full text
Pauline A. Waight, Nicholas J. Andrews, Shamez Ladhani et al. · The Lancet Infectious Diseases · 2015 · 597 citations · Full text
Veterinary Medicine, Infectious Diseases, Preventive Medicine +17
Daniel R. Feikin, E. Wangeci Kagucia, Jennifer D. Loo et al. · PLoS Medicine · 2013 · 480 citations · Full text
Veterinary Medicine, Infectious Diseases, Preventive Medicine +16